A study of ASP3082 in adults with advanced solid tumors
3082-CL-0101
Phase 1 other active
Quick answer
A study of ASP3082 in adults with advanced solid tumors for Solid Tumor is a Phase 1 program (other) at Astellas Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Astellas Pharma GmbH
- Indication
- Solid Tumor
- Phase
- Phase 1
- Modality
- other
- Status
- active